These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35917868)

  • 1. Solid state of inhalable high dose powders.
    Adhikari BR; Gordon KC; Das SC
    Adv Drug Deliv Rev; 2022 Oct; 189():114468. PubMed ID: 35917868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system.
    Alhajj N; O'Reilly NJ; Cathcart H
    Int J Pharm; 2022 Apr; 618():121657. PubMed ID: 35288220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria.
    Wang J; Kutter JP; Mu H; Moodley A; Yang M
    Int J Pharm; 2020 Nov; 590():119877. PubMed ID: 32927003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study on polymorphic forms of rifampicin for inhaled high dose delivery in tuberculosis treatment.
    Khadka P; Hill PC; Zhang B; Katare R; Dummer J; Das SC
    Int J Pharm; 2020 Sep; 587():119602. PubMed ID: 32663580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization,
    Acosta MF; Muralidharan P; Grijalva CL; Abrahamson MD; Hayes D; Fineman JR; Black SM; Mansour HM
    Ther Adv Respir Dis; 2021; 15():1753466621998245. PubMed ID: 33719747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W; Rades T; Rantanen J; Yang M
    Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Solid-State Properties on the Aerosolization Performance of Spray-Dried Curcumin Powders.
    Zhang Q; Li Y; Li L; Cheng Y; Yu F; Li R; Hou S
    AAPS PharmSciTech; 2023 Mar; 24(3):78. PubMed ID: 36918500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers.
    Acosta MF; Abrahamson MD; Encinas-Basurto D; Fineman JR; Black SM; Mansour HM
    AAPS J; 2020 Nov; 23(1):2. PubMed ID: 33200330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections.
    Momin MAM; Tucker IG; Doyle CS; Denman JA; Sinha S; Das SC
    Int J Pharm; 2018 Apr; 541(1-2):26-36. PubMed ID: 29458207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying.
    Saboti D; Maver U; Chan HK; Planinšek O
    J Pharm Sci; 2017 Jul; 106(7):1881-1888. PubMed ID: 28285981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
    Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acids improve aerosolization and chemical stability of potential inhalable amorphous Spray-dried ceftazidime for Pseudomonas aeruginosa lung infection.
    Adhikari BR; Sinha S; Gordon KC; Das SC
    Int J Pharm; 2022 Jun; 621():121799. PubMed ID: 35525472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis.
    Momin MAM; Sinha S; Tucker IG; Doyle C; Das SC
    Int J Pharm; 2017 Aug; 528(1-2):107-117. PubMed ID: 28583333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
    Eedara BB; Tucker IG; Das SC
    Int J Pharm; 2016 Jun; 506(1-2):174-83. PubMed ID: 27091294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
    Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
    Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of l-Carnitine and l-Carnitine HCL salt for targeted lung treatment of pulmonary hypertension (PH) as inhalation aerosols: Design, comprehensive characterization, in vitro 2D/3D cell cultures, and in vivo MCT-Rat model of PH.
    Acosta MF; Muralidhran P; Abrahamson MD; Grijalva CL; Carver M; Tang H; Klinger C; Fineman JR; Black SM; Mansour HM
    Pulm Pharmacol Ther; 2020 Dec; 65():101998. PubMed ID: 33556627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and Characterization of Inhalable Ivermectin Powders as a Potential COVID-19 Therapy.
    Albariqi AH; Ke WR; Khanal D; Kalfas S; Tang P; Britton WJ; Drago J; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2022 Oct; 35(5):239-251. PubMed ID: 35275749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.